Pierre Legault

Insider Reports History

Location
Berwyne, PA
Signature
s/ Michael A. Metzger, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Pierre Legault:

Company Role Class Num Shares Value Price $ Report Date Ownership
Syndax Pharmaceuticals Inc Director Common Stock 90,000 $1,802,682 $20.03 05 Feb 2025 Direct
BICYCLE THERAPEUTICS PLC Director Ordinary Shares 46,000 $690,000 $15 02 Jan 2025 Direct
BICYCLE THERAPEUTICS PLC Director Stock Option (right to buy) 25,000 02 Jan 2025 Direct

Insider Reports Filed by Pierre Legault

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SNDX Syndax Pharmaceuticals Inc 05 Feb 2025 1 $0 4 Director 07 Feb 2025, 16:32
BCYC BICYCLE THERAPEUTICS PLC 02 Jan 2025 2 $0 4 Director 06 Jan 2025, 19:30
SNDX Syndax Pharmaceuticals Inc 07 Feb 2024 1 $0 4 Director 09 Feb 2024, 16:04
BCYC BICYCLE THERAPEUTICS plc 02 Jan 2024 2 $0 4 Director 04 Jan 2024, 18:35
SNDX Syndax Pharmaceuticals Inc 02 Feb 2023 1 $0 4 Director 03 Feb 2023, 15:54
SNDX Syndax Pharmaceuticals Inc 12 Jan 2023 9 -$615,801 4 Director 13 Jan 2023, 15:44
BCYC BICYCLE THERAPEUTICS plc 03 Jan 2023 2 $0 4 Director 05 Jan 2023, 20:05
SNDX Syndax Pharmaceuticals Inc 05 Aug 2022 6 -$331,061 4 Director 09 Aug 2022, 16:05
SNDX Syndax Pharmaceuticals Inc 02 Feb 2022 1 $0 4 Director 03 Feb 2022, 16:30
BCYC BICYCLE THERAPEUTICS plc 03 Jan 2022 2 $0 4 Director 05 Jan 2022, 16:24
BCYC BICYCLE THERAPEUTICS plc 20 Dec 2021 9 -$7,384,203 4 Director 22 Dec 2021, 20:00
SNDX Syndax Pharmaceuticals Inc 20 Dec 2021 6 -$617,736 4 Director 22 Dec 2021, 17:25